Overexpression of hexokinase-2, which was detected in diverse cancers, including lung, liver, breast, ovarian, gastric cancers and esophageal adenocarcinoma, not only compensates for the increased energy demands of cancer cells, but also confers tolerance to chemotherapy/radiotherapy and apoptosis resistance [16, 19–21]. This evidence concerns the gene HK2 and cancer.